Navigation Links
CMSI produces Low cost Anti-retroviral drugs in India

Comprehensive Medical Services India (CMSI) has produced two Anti-retrovirals which can be used in the treatment of HIV/AIDS. The two drugs Nevirapine and Zidovudine is produced by CMSI in its // manufacturing unit in Chennai, India. These two drugs were officially released by Sebastian Ouseperamppil, Director-general, Catholic Health Association. A new microbiology department which could maintain the quality control and Research facilities was dedicated to this manufacturing unit.

The two drugs, Nevirapine and Zidovudine, manufactured by the Essential Drug project of the CMSI, are now available at “reasonable” rates. The organization will soon make available the other components of the ARV tri-drug therapy: Lamivudine, Efaravenz and Combinations of Lamivudine, Stavudine and Nevirapine in various strengths, said CMSI executive trustee-director Moses P. Manohar. Jane Masiga, from the Mission for Essential Drugs and Supplies, Nairobi, Kenya, received the first consignment of Zidovudine capsules from Bimal Charles, Epidemiologist, Center for Disease Control.

Dr. Charles of Center for Disease Control said that the company should maintain the quality of the drugs without compromising on the cost of the drug by maintaining strict quality control measures. He said that the AIDS drugs which was very expensive and is less affordable by economically weaker section has become cheaper and could be affordably brought by the patients.

Page: 1

Related medicine news :

1. Five AIDS Patients To Receive Experimental Anti-retroviral Drugs
2. Anti-retroviral drug conserving trial halted
3. One Lakh HIV Patients to get Free Anti-retroviral Drugs by 2007
4. Mental Illness Reversed with Anti-retrovirals in HIV Cases
5. Cancer drugs in development nearly doubled since 1995
6. Cipla holds talks with mining giant to supply AIDS drugs for South African workers
7. African HIV strains more resistant to anti HIV drugs
8. Right drugs drastically cut stroke risk
9. Relating heart protection and antihypertensive drugs
10. Enzyme may be target for obesity drugs
11. New HIV cases resist drugs
Post Your Comments:

(Date:11/27/2015)... , ... November 27, 2015 , ... Avid collector, Andrew ... Arbor Michigan boxing style concert posters. This is one of Joplin's most famous and ... House at the University of Michigan in Ann Arbor. The According to Hawley, "It ...
(Date:11/26/2015)... ... November 26, 2015 , ... Inevitably when people think Thanksgiving, they also ... buy during the Black Friday and Cyber Monday massage chair sales to ... Internet high and low to find the best massage chair deals, they can see ...
(Date:11/26/2015)... (PRWEB) , ... November 26, 2015 , ... ... of workshops to discuss bioavailability and the need to integrate dose form selection ... in collaboration with OBN, the membership organization supporting and bringing together the UK’s ...
(Date:11/26/2015)... ... November 26, 2015 , ... WorldCare International, ... in the 61st annual Employee Benefits Conference. The Employee Benefits Conference was hosted ... 8th through Wednesday, November 11th, 2015. The conference was held at the Hawaii ...
(Date:11/26/2015)... ... 2015 , ... Indosoft Inc., developer and distributor of the world-class Asterisk based ... efficiency and reliability. , The new Q-Suite 6 platform is based on the latest ... itself into a specific piece of software for many key components of the suite. ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... ) ... "2016 Global Tumor Marker Testing Market: Supplier ... Segment Forecasts, Innovative Technologies, Instrumentation Review, Competitive ... offering. --> ) has ... Global Tumor Marker Testing Market: Supplier Shares ...
(Date:11/26/2015)... , Países Bajos, November 26, 2015 ... terapia fotodinámica de Bremachlorin para el cáncer avanzado. ... inmunoterapia con la terapia fotodinámica de Bremachlorin para el ... nuevo enfoque combina la inmunoterapia con la terapia fotodinámica ... Clinical Cancer Research . --> Clinical ...
(Date:11/26/2015)... , November 26, 2015 ... new combination approach blends immunotherapy with Bremachlorin-photodynamic therapy for ... combination approach blends immunotherapy with Bremachlorin-photodynamic therapy for advanced ... combination approach blends immunotherapy with Bremachlorin-photodynamic therapy for advanced ... has found that immunotherapy can be efficiently combined ...
Breaking Medicine Technology: